Back to search

Article

Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin

2004-06-15

Abstract excerpt

Small molecule inhibitors, such as imatinib, are effective therapies for tyrosine kinase fusions BCR-ABL–TEL-PDGFβR–mediated human leukemias, but resistance may develop. The unique fusion junctions of these molecules are attractive candidates for molecularly targeted therapeutic intervention using RNA interference (RNAi), which is mediated by small interfering RNA (siRNA). We developed a retroviral system for stab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36fa0cf5-7280-5928-b0a0-a59013003bec
DOI
10.1172/jci200420673
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycinDOI 10.1172/jci200420673
Select a neighboring publication to make it the new centre.